| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |